Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
Añadir filtros








Intervalo de año
1.
Artículo en Inglés | IMSEAR | ID: sea-91824

RESUMEN

AIM OF STUDY: Quality of life (QOL) as outcome during treatment of acid peptic disease has been studied, but, peptic perforation, which is the commonest complication of acid peptic disease, has not been studied in the light of QOL outcome. The present-study addresses the important issue of QOL after peptic perforations. METHODS: This prospective study was carried on 51 adult consecutive survivors of peptic perforation managed in Gastrointestinal Surgery Unit, Department of Surgery, Government NSCB Medical College and Hospital, Jabalpur (MP) India. These underwent exploratory laparotomy with repair of perforation, and subsequently were discharged on anti-ulcer therapy (Pantoprazole 40 mg once a day) for 6 weeks. The instrument chosen to study their QOL was gastrointestinal quality of life index (GIQLI). Patients were assessed before they underwent surgery and 3 months and 6 months after operation. RESULTS: The overall GIQLI score (t = 20.1, p < 0.00 at 3 months; t = 8.2, p < 0.001 at 6 months) as well as its G I core (t = 14.5, p < 0.001 at 3 months; t = 7.3, p < 0.001 at 6 months), G I disease specific (t = 12.9, p < 0.001 at 3 months; t = 2.6, p < 0.02 at 6 months), psychological (t = 15.4, p < 0.001 at 3 months; t = 3.5, p < 0.001 at 6 months) and physical and social components (t = 10.9, p < 0.001 at 3 months; t = 4.2, p < 0.001 at 6 months) significantly increased over 3 and 6 months of follow-up, reflecting improvement in quality of life as perceived by the patients. Variations in the pattern of recovery, based on age and gender were not seen in the present study. CONCLUSION: Peptic perforation does not result in any long lasting impairment of QOL and the QOL improves to near normal in 6 months time after the perforation.


Asunto(s)
2-Piridinilmetilsulfinilbencimidazoles , Adulto , Anciano , Anciano de 80 o más Años , Antiulcerosos/uso terapéutico , Bencimidazoles/uso terapéutico , Procedimientos Quirúrgicos del Sistema Digestivo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Omeprazol/análogos & derivados , Evaluación de Resultado en la Atención de Salud , Úlcera Péptica Perforada/tratamiento farmacológico , Estudios Prospectivos , Calidad de Vida , Encuestas y Cuestionarios , Perfil de Impacto de Enfermedad , Sulfóxidos/uso terapéutico
4.
Indian Pediatr ; 1993 Mar; 30(3): 428-9
Artículo en Inglés | IMSEAR | ID: sea-14750
7.
Indian Pediatr ; 1981 Jul; 18(7): 495-6
Artículo en Inglés | IMSEAR | ID: sea-10466
8.
Indian Pediatr ; 1981 Mar; 18(3): 193-7
Artículo en Inglés | IMSEAR | ID: sea-12676
10.
Indian Pediatr ; 1980 Aug; 17(8): 709
Artículo en Inglés | IMSEAR | ID: sea-14595
15.
Indian J Pediatr ; 1977 Sep; 44(356): 253-6
Artículo en Inglés | IMSEAR | ID: sea-83483
17.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA